CIDH White Paper: Scalable Partnership Framework to Streamline Digital Health Research

Digital transformation remains a strategic priority for many biopharmaceutical companies to bring products to market faster to gain a competitive edge. Yet, most biopharma companies do not have an internal team to successfully develop, validate, scale, and implement digital health solutions.
CIDH is excited to present our newly published white paper, which outlines how our expansive network of advisors, faculty, and experts throughout Mass General Brigham can partner with biopharma companies to support the acceleration of digital health solutions.
Find out how we helped two of our industry partners–AstraZeneca and Fern Health–to successfully expedite their digital health innovations here.
